Webster Bank’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Webster Bank’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-80,000	Closed	-$35K	–	544
2022 Q2	$35K	Hold	80,000	–	–	﹤0.01%	352
2022 Q1	$101K	Hold	80,000	–	–	0.01%	263
2021 Q4	$104K	Hold	80,000	–	–	0.01%	263
2021 Q3	$165K	Hold	80,000	–	–	0.02%	207
2021 Q2	$126K	Buy	80,000 +10,000	+14%	+$18.5K	0.01%	232
2021 Q1	$155K	Hold	70,000	–	–	0.02%	225
2020 Q4	$174K	Hold	70,000	–	–	0.02%	217
2020 Q3	$172K	Buy	70,000 +10,000	+17%	+$29.1K	0.02%	207
2020 Q2	$213K	Hold	60,000	–	–	0.03%	181
2020 Q1	$140K	Hold	60,000	–	–	0.02%	196
2019 Q4	$132K	Hold	60,000	–	–	0.02%	226
2019 Q3	$110K	Hold	60,000	–	–	0.01%	239
2019 Q2	$87K	Hold	60,000	–	–	0.01%	256
2019 Q1	$118K	Hold	60,000	–	–	0.02%	230
2018 Q4	$79K	Hold	60,000	–	–	0.01%	250
2018 Q3	$148K	Buy	60,000 +10,000	+20%	+$29.5K	0.02%	233
2018 Q2	$168K	Hold	50,000	–	–	0.02%	216
2018 Q1	$212K	Hold	50,000	–	–	0.03%	199
2017 Q4	$165K	Hold	50,000	–	–	0.02%	227
2017 Q3	$191K	Hold	50,000	–	–	0.03%	214
2017 Q2	$220K	Buy	50,000 +10,000	+25%	+$41.1K	0.03%	201
2017 Q1	$145K	Hold	40,000	–	–	0.02%	249
2016 Q4	$107K	Hold	40,000	–	–	0.02%	261
2016 Q3	$130K	Buy	40,000 +10,000	+33%	+$32.7K	0.02%	208
2016 Q2	$101K	Hold	30,000	–	–	0.01%	204
2016 Q1	$73K	Buy	30,000 +10,000	+50%	+$23.6K	0.01%	204
2015 Q4	$66K	Hold	20,000	–	–	0.01%	212
2015 Q3	$69K	Hold	20,000	–	–	0.01%	190
2015 Q2	$27K	Buy	+20,000	New	+$27.9K	﹤0.01%	189
2014 Q4	–	Sell	-19,657	Closed	-$86K	–	209
2014 Q3	$86K	Buy	+19,657	New	+$96.3K	0.02%	194

Other funds holding NYMX

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FCFC

First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Webster Bank's NYMX Position: Q3 2022 in Review

Webster Bank sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2022, closing a stake of 80,000 shares — an estimated $35K sold.

Webster Bank first reported a position in NYMX in Q3 2014 and held it in 30 quarters. The position peaked at $220K in Q2 2017. 34 funds tracked by Wall St. Rank hold NYMX as of Q3 2022.

Webster Bank reported no remaining Nymox Pharmaceutical Corp position as of Q3 2022 after selling out during the quarter.
Webster Bank sold 80,000 Nymox Pharmaceutical Corp shares in Q3 2022, an estimated $35K.
Webster Bank first reported a position in Nymox Pharmaceutical Corp in Q3 2014 and held it in 30 quarters.
Webster Bank's Nymox Pharmaceutical Corp position peaked at $220K in Q2 2017.
34 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2022.

Based on Webster Bank's 13F filing for Q3 2022, filed 24 Oct 2022.